Warren Buffett’s firm trims stakes in drug makers, finance companies
OMAHA, Neb. — Investor Warren Buffett’s company made two new investments during the third quarter while trimming its holdings in several drug makers and financial firms.
Berkshire Hathaway Inc. BRK.B,
The conglomerate based in Omaha, Nebraska, said its newest holdings included $475 million worth of shares of Royalty Pharma RPRX,
Besides those two new investments and a move to increase its stake in Chevron CVX,
Buffett and other Berkshire officials don’t comment on these quarterly stock filings, and the reports don’t make it clear whether either of the company’s two other investment managers had a hand in the moves. Buffett generally handles all the bigger investments in Berkshire’s portfolio that are worth more than $1 billion apiece such as longstanding holdings in Coca-Cola KO,
With Chevron, Berkshire bought nearly 5.6 million shares to rebuild part of the investment it had been selling off in the first half of this year, but Berkshire’s current $2.9 billion investment in the oil giant is still smaller than the $4.1 billion Chevron stake it established late last year.
During the third quarter, Berkshire sold off its investments in Merck MRK,
Berkshire also scaled back its investments in Visa V,
Besides investments, Berkshire owns more than 90 companies outright, including BNSF railroad, Geico insurance and several major utilities. The conglomerate also owns manufacturing, furniture, shoe, jewelry, chocolate, underwear and brick companies.